Coronary Heart Disease Diagnosis
Coronary Heart Disease Diagnosis
Every coronary diagnosis answers one of two opposite questions. Is disease present at all — a question of exclusion, answered without a catheter whenever possible. Or is this artery worth treating — a question of anatomy and ischaemia, answered inside the catheterisation laboratory, where treatment can follow the map in the same sitting. The tests are arranged along that line, and knowing which question you are being asked is the quickest way to understand why one patient goes to a scanner and another goes to a catheterisation room.
The first tests: ECG and troponin
Everything begins with two tests that take minutes. The electrocardiogram records the heart's electrical surface and is read for one question first: is an artery closing right now? The pattern of an acute full blockage — the ST elevation of a STEMI — is visible immediately and changes the day's plan to emergency reperfusion. The ECG is also honest about its limits: most stable narrowings leave it entirely normal, and a normal ECG never excludes coronary disease.
The high-sensitivity troponin blood test detects the protein released when heart muscle is injured. Taken at presentation and repeated a few hours later, it separates a heart attack (troponin rising) from unstable angina (the same clinical picture, troponin normal) — a distinction that changes the urgency of everything that follows. Together with the history, these two tests are how chest pain is triaged; they are not how the arteries are seen.
Coronary CT angiography: ruling disease out without a catheter
The coronary CT angiogram is a contrast-enhanced scan, timed to the heartbeat, that shows the coronary arteries and their walls from the outside. Its strength is as a rule-out test: in a patient with lower-risk symptoms, a clean scan reliably excludes significant coronary disease and ends the investigation — no catheter, no admission, often no further testing at all. It also sees what an angiogram cannot: the plaque inside the artery wall, including the soft, lipid-rich plaques that may not yet be narrowing the channel but carry the rupture risk.
Invasive angiography: the definitive map
The coronary angiogram is the test from which treatment decisions are made. A thin catheter is threaded from the wrist (radial artery — the usual route, which lets patients sit up and walk immediately afterwards) or the groin into the coronary arteries, contrast is injected, and every artery is filmed from several angles. The result is the map: which arteries are narrowed, where, how severely, what the collateral supply looks like, and whether the anatomy suits a wire or a graft.
The pressure wire: FFR and iFR
An angiogram shows what a narrowing looks like; a pressure-wire measurement shows what it does. A wire the width of a hair is passed across the narrowing and the pressure drop across it is measured — during maximal flow, or at rest with a period of hyperaemia induced. The result, called FFR (fractional flow reserve) or iFR (instantaneous wave-free ratio), answers a question the picture cannot: is this narrowing actually starving the muscle?
The consequence is one of the most useful reversals in modern cardiology: a moderate narrowing — the 50–70% lesions that look decisive on film — often fails the test, and when it does, stenting it adds risk without benefit; the patient is treated with medicine and the artery is left alone. The measurement is spent where the answer would change the plan: on intermediate lesions, on the vessel supplying a large territory, and on deciding how much of a multivessel disease really needs treating. For the visiting patient, this is a test worth asking about by name — it is the difference between an angiogram that invites treatment and one that justifies it.
Risk stratification: how urgency and complexity are scored
Two scoring systems run alongside the tests, and they are the reason two patients with the same-looking narrowing can be treated on different calendars.
- Urgency, in the acute setting: patients with an acute coronary syndrome are risk-scored (the GRACE score and similar tools combine age, ECG changes, troponin, blood pressure, kidney function and heart rate) into categories from "open the artery within hours" to "investigate during this admission". The score is how the phrase "very high risk" in a report becomes a clock.
- Complexity, before the decision: the anatomy is scored for how difficult and how extensive the disease is — the number of vessels, the left main artery, calcification, bifurcations, chronic total occlusions. Scores in this family (SYNTAX and its successors) are the framework of the stent-versus-bypass comparison: low complexity favours a stent, high complexity shifts the balance toward surgery, and the middle ground is where the heart team discussion happens.
Neither score predicts what will happen to an individual patient, and neither is meant to. Their value is that they turn "who first, and how" into a judgement that can be discussed, compared and reviewed — rather than the private impression of whichever clinician happens to be on duty.
What a complete assessment should answer
However the tests are assembled — CT scan, angiogram, wire, echo — the diagnosis is not complete until the report answers six things, and patients can check their own report against this list:
- Which arteries are narrowed, where, and how severely — named vessels and segments, not a percentage alone.
- Whether the concerning narrowings are ischaemic — pressure-wire or stress-imaging evidence, not appearance alone.
- The pumping function — the ejection fraction, and whether any wall moves abnormally.
- The complexity score — where the anatomy sits in the stent-versus-bypass framework.
- The urgency — what the risk score says about how fast this needs to happen.
- The risk factors — the cholesterol, blood pressure, diabetes and smoking status that the treatment plan must address whatever the arteries get.